NexgenRx, Inc. engages in the provision of administrative services only (ASO) (Self-Funded) drug, dental and extended health benefit plans supported by technology. The company is headquartered in Toronto, Ontario. The company went IPO on 2006-09-14. The firm administers, adjudicates and pays drug, dental and other extended healthcare claims for the beneficiaries of health benefit plans underwritten by its customers, using proprietary computer software and also providing ancillary services. The company offers plan sponsors, providers and patient support program/drug manufacturers a full suite of software-as-a-service solutions. The Company’s products include NexSys, NexAdmin, and NexPSPAssist. The NexSys is a fully integrated rules based adjudication platform for secure real-time processing of drug, dental and extended health benefit claims. Its NexAdmin product enables sponsors to take complete control of benefit plan administration. The NexPSPAssist service helps patient support programs (PSP) to optimize their deliverables to their manufacturer clients.
Chiffres en millions de dollars américains. L'exercice financier va de février à janvier.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenus
17
16
13
12
11
10
Croissance des revenus (H/H)
6%
23%
8%
9%
10%
11%
Coût des ventes
3
3
3
2
2
1
Bénéfice brut
14
13
10
10
9
9
Vente, Général et Administration
11
10
9
8
6
6
Recherche et développement
--
--
--
--
--
--
Frais d'exploitation
12
12
11
10
7
7
Autres revenus (charges) non opérationnels
--
--
--
--
--
--
Bénéfice avant impôts
1
1
0
0
2
1
Charge d'impôt sur le revenu
0
0
0
0
-2
0
Bénéfice net
1
0
0
0
4
2
Croissance du bénéfice net
--
--
--
-100%
100%
--
Actions en circulation (diluées)
84.25
70.93
70.53
70.33
74.83
69.91
Variation des actions (H-H)
10%
1%
0%
-6%
7%
0%
EPS (dilué)
0.01
0
0
0
0.05
0.03
Croissance du EPS
425%
-285%
1,467%
-101%
77%
-1,110%
Flux de trésorerie libre
2
0
1
0
3
2
Flux de trésorerie libre par action
--
--
--
--
--
--
Marge brute
82.35%
81.25%
76.92%
83.33%
81.81%
90%
Marge opérationnelle
5.88%
6.25%
0%
0%
18.18%
10%
Marge bénéficiaire
5.88%
0%
0%
0%
36.36%
20%
Marge du flux de trésorerie libre
11.76%
0%
7.69%
0%
27.27%
20%
EBITDA
2
2
1
1
3
1
Marge EBITDA
11.76%
12.5%
7.69%
8.33%
27.27%
10%
D&A pour le résultat opérationnel
1
1
1
1
1
0
EBIT
1
1
0
0
2
1
Marge EBIT
5.88%
6.25%
0%
0%
18.18%
10%
Taux d'imposition effectif
0%
0%
0%
0%
-100%
0%
Follow-Up Questions
NexgenRx Inc.'in temel mali tabloları nelerdir?
Son mali tabloya (Form-10K) göre, NexgenRx Inc.'in toplam varlıkları $30 olup, net perte $0'dir.
NEGXF'ün temel finansal oranları nelerdir?
NexgenRx Inc.'in cari oranı 1.36, net kâr marjı 0, hisse başına satış $0.22'dir.
NexgenRx Inc.'in geliri segment veya coğrafya bazında nasıl dağılıyor?
Le segment de revenus le plus important est NexgenRx Inc., avec un chiffre d'affaires de Administration Fees lors du dernier rapport de résultats. En termes géographiques, Canada est le marché principal pour NexgenRx Inc., avec un chiffre d'affaires de 13,846,329.
NexgenRx Inc. kârlı mı?
non, son mali tablolara göre NexgenRx Inc.'in net perte $0'dir.
NexgenRx Inc.'in herhangi bir yükümlülüğü var mı?
oui, NexgenRx Inc.'in yükümlülüğü 22'dir.
NexgenRx Inc.'in tedavüldeki hisse sayısı kaçtır?
NexgenRx Inc.'in toplam tedavüldeki hisse sayısı 71.11'dir.